|Articles|October 1, 2002

New Directions for Type 2 Diabetes Mellitus Management
Volume 8
Issue 16 Suppl

Effects of Thiazolidinediones for Early Treatment of Type 2 Diabetes Mellitus

Author(s)David J. Kudzma, MD

Download PDF: Effects of Thiazolidinediones for Early Treatment of Type 2 Diabetes Mellitus

Articles in this issue

over 23 years ago

Article

Participating Faculty

over 23 years ago

Article

New Directions for Type 2 Diabetes Mellitus Management

over 23 years ago

Article

Long-term Consequences of Type 2 Diabetes Mellitus: Economic Impact on Society and Managed Care

over 23 years ago

Article

Understanding Type 2 Diabetes Mellitus and Associated Cardiovascular Disease: Linked by Insulin Resistance

over 23 years ago

Article

Current Treatment Approaches of Type 2 Diabetes Mellitus: Successes and Shortcomings

over 23 years ago

Article

Thiazolidinediones in the Treatment of Managed Care Patients with Type 2 Diabetes

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Effects of Thiazolidinediones for Early Treatment of Type 2 Diabetes Mellitus

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity